ORKA Q2 2022 Earnings — Oruka Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

ORKAOruka Therapeutics, Inc.

$1B

Q2 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$29,000

Operating Income

-$2M

Net Income

-$3M

EPS (Diluted)

$-2.62

QoQ Revenue Growth

NaN%

Balance Sheet

Total Assets

$48M

Total Liabilities

$3M

Stockholders' Equity

$45M

Cash & Equivalents

$46M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$29,000	-$19,000	-52.6%
Operating Income	-$2M	-$5M	+49.8%
Net Income	-$3M	-$5M	+34.9%